Form 4: Clorox CEO Rendle Boosts Stake with RSU Grant

Clorox CEO Linda J Rendle increased her beneficial ownership by 34,281 shares of common stock through a Restricted Stock Unit grant valued at approximately $4.28 million.

Summary

• Linda J Rendle, Chief Executive Officer and Director of The Clorox Company, acquired 34,281 shares of common stock.
• The transaction occurred on September 16, 2025, at a price of $124.85 per share.
• The acquisition was made through a Restricted Stock Unit (RSU) grant.
• These RSUs will vest in four equal annual installments, beginning on October 5, 2026, and continuing through October 5, 2029.
• Following this transaction, Linda J Rendle beneficially owns 167,537 shares of Clorox common stock.
• The total value of the acquired shares at the transaction price is approximately $4,279,999.85.

Sentiment

Score: 6

Explanation: The acquisition of shares by the CEO, even through an RSU grant, is generally viewed as a positive signal, indicating alignment of interests and potential confidence in future performance. It's not a direct open market purchase, hence not a 'strong buy' signal, but still favorable.

Positives

• The CEO's increased beneficial ownership aligns her interests more closely with those of shareholders.
• The acquisition of shares, even through a grant, can signal management's confidence in the company's long-term prospects.

Risks

• The value of the RSU grant is subject to the future market price of Clorox common stock.
• The vesting schedule means the full benefit of the grant is contingent on continued employment and company performance over several years.

Future Outlook

The vesting schedule for the Restricted Stock Units indicates a long-term commitment from the CEO, with shares vesting annually over the next four years, contingent on continued employment and potentially performance metrics.

Industry Context

Executive compensation packages frequently include equity grants like Restricted Stock Units to align management incentives with long-term shareholder value creation. This is a standard practice in publicly traded companies across various industries, including consumer goods.

Stakeholder Impact

• Shareholders: Increased alignment of CEO's financial interests with long-term shareholder value.
• Employees: May signal stability and confidence in leadership.

Next Steps

• First tranche of Restricted Stock Units will vest on October 5, 2026.
• Subsequent tranches will vest annually on October 5, 2027, 2028, and 2029.

Key Dates

Recommendation

The Form 4 filing reports an executive compensation grant, specifically Restricted Stock Units, which increases the CEO's beneficial ownership. While this is a positive signal for aligning management's interests with shareholders and can indicate confidence in the company's future, it is not an open-market purchase. Without additional financial context or operational updates, this single transaction is typically not sufficient to warrant a 'buy' or 'sell' recommendation, thus a 'hold' is appropriate as it reinforces existing positions rather than suggesting a new entry or exit.

Keywords

CLX, Clorox, Form 4, Insider Transaction, CEO, Linda Rendle, Restricted Stock Units, Equity Compensation, Beneficial Ownership